Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.
about
M2e-Based Universal Influenza A VaccinesNanoscale bacteriophage biosensors beyond phage display.Bacteriophages and Their Immunological Applications against Infectious Threats.Potential recombinant vaccine against influenza A virus based on M2e displayed on nodaviral capsid nanoparticles.The prospects and challenges of universal vaccines for influenzaThe smart targeting of nanoparticlesBacteriophage-fused peptides for serodiagnosis of human strongyloidiasis.Induction of humoral and cell-mediated immune responses by hepatitis B virus epitope displayed on the virus-like particles of prawn nodavirusA novel M2e based flu vaccine formulation for dogs.Structural basis for the development of avian virus capsids that display influenza virus proteins and induce protective immunity.Protection against Influenza A Virus Challenge with M2e-Displaying Filamentous Escherichia coli Phages.Supplementation of inactivated influenza vaccine with norovirus P particle-M2e chimeric vaccine enhances protection against heterologous virus challenge in chickens.Novel vaccine strategies against emerging viruses.A novel subnucleocapsid nanoplatform for mucosal vaccination against influenza virus that targets the ectodomain of matrix protein 2.Gold nanoparticle-M2e conjugate coformulated with CpG induces protective immunity against influenza A virus.Construction of recombinant bacmid containing m2e-ctxb and producing the fusion protein in insect cell linesVaccine design: emerging concepts and renewed optimism.Nanomaterials for enhanced immunity as an innovative paradigm in nanomedicine.Genetically modified bacteriophages in applied microbiology.An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice.Bacteriophages and their derivatives for the treatment and control of food-producing animal infections.A dual purpose universal influenza vaccine candidate confers protective immunity against anthrax.M2-based influenza vaccines: recent advances and clinical potential.Advances in the study of nodavirus.Immunogenicity and efficacy of replication-competent recombinant influenza virus carrying multimeric M2 extracellular domains in a chimeric hemagglutinin conjugate.Development of a novel dual-domain nanoparticle antigen construct for universal influenza vaccine.
P2860
Q26783493-EEFA6308-9314-4E4B-BC6B-7CF9691159FFQ28389760-907FD817-1B9B-473B-A693-748B4344737AQ30234522-6E105C90-6235-4EFF-8096-63F558A5C81BQ30373993-1EA09D7D-0927-45AF-ADDD-80574BAFA7C6Q30430703-1C69CAD1-8548-4DE6-8BD2-D6A87C7CB1F3Q33593665-94EA997F-4E10-444E-BC99-E12CDCD194D2Q33685519-C3F81A4C-3634-440C-8305-4EFD5D7F2F97Q34933721-97F190DC-9B04-4B3A-9DA8-062A1D465E12Q35009732-85409B74-D541-43C6-860F-AE7D2A4601F3Q35076683-93074F54-9CAA-4E7A-B449-362BC2D485D0Q35606494-7945F61E-5A2A-4D89-B3EF-C3E3F93BF271Q36267431-336DFB3D-6B8B-4EDE-8BA0-9438ECD32E93Q36816140-CCEE789F-E8DE-44DC-97BE-25BEE388101EQ37547653-2651D1B6-D3B8-4BBE-967C-08354055DF4FQ37645689-12F8B523-47A4-4FDF-8A47-42E9D3144CBFQ37663318-5144687F-8F41-403C-8F90-8189F87065E5Q38087785-784A70C6-79A5-477F-9C86-F0E5093BF346Q38418305-5D718511-A2CA-4932-A73C-0A735B4D0A98Q38870317-585F215F-64D4-493D-BC17-DF20F95D1D7CQ38971243-4223F7F6-2EFD-4EEC-85FC-AD4ED9A3BDE2Q39029801-29928696-B4CD-4A03-91F8-4DC1094900A8Q40489092-9623D5D1-DAF3-4BDD-9269-17DDF0655CFCQ40571808-B5FDA09E-64D1-4302-9E75-EB710684120FQ41925816-C41D0E37-F0C7-446D-9F4D-D46230CF09AAQ45325239-02E8D305-6C8B-4EE3-AE6F-9BC1AF8B3924Q47442073-C7DDBF0B-868B-4C9E-89E2-6A9B343BB6F1
P2860
Immunization with M2e-displaying T7 bacteriophage nanoparticles protects against influenza A virus challenge.
description
2012 nî lūn-bûn
@nan
2012 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Immunization with M2e-displayi ...... t influenza A virus challenge.
@ast
Immunization with M2e-displayi ...... t influenza A virus challenge.
@en
Immunization with M2e-displayi ...... t influenza A virus challenge.
@nl
type
label
Immunization with M2e-displayi ...... t influenza A virus challenge.
@ast
Immunization with M2e-displayi ...... t influenza A virus challenge.
@en
Immunization with M2e-displayi ...... t influenza A virus challenge.
@nl
prefLabel
Immunization with M2e-displayi ...... t influenza A virus challenge.
@ast
Immunization with M2e-displayi ...... t influenza A virus challenge.
@en
Immunization with M2e-displayi ...... t influenza A virus challenge.
@nl
P2093
P2860
P921
P1433
P1476
Immunization with M2e-displayi ...... t influenza A virus challenge.
@en
P2093
Hamidreza Hashemi
Somayeh Pouyanfard
Talat Mokhtari-Azad
Xavier Saelens
Zahra Noroozbabaei
P2860
P304
P356
10.1371/JOURNAL.PONE.0045765
P407
P577
2012-09-24T00:00:00Z